


Ask a doctor about a prescription for BEPANMED 500 mg/2 ml INJECTABLE SOLUTION
Package Leaflet: Information for the Patient
Bepanmed 500 mg/2 ml Solution for Injection
Dexpantenol
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
Bepanmed 500 mg/2 ml Solution for Injection contains the active substance dexpantenol, similar to a vitamin of the B group, pantothenic acid.
Bepanmed is indicated in states of pantothenic acid deficiency, which may produce cases such as the following: Loss of intestinal muscle tone (intestinal atony) caused after an operation or by intestinal obstruction (paralytic ileus); and in cases of Burning Feet Syndrome caused by a deficiency of vitamin B5, pantothenic acid.
Do not use Bepanmed:
Warnings and Precautions
Consult your doctor or pharmacist before starting to use Bepanmed.
Children
Do not administer Bepanmed to children under 18 years of age, as there are no data available for this age group.
Other Medications and Bepanmed
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Patients being treated with succinylcholine (suxamethonium chloride) should not use dexpantenol (this medication) within one hour after administration of succinylcholine, due to possible prolongation of muscle relaxant effect.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
As a precaution, it is preferable not to use Bepanmed during pregnancy.
Breastfeeding
The risk to newborns/children cannot be excluded, as it is unknown whether dexpantenol passes into breast milk.
Your doctor will decide whether it is necessary to interrupt breastfeeding or treatment, considering the benefit of breastfeeding for the child and the benefit of treatment for the mother.
Fertility
Due to the lack of data, it cannot be determined whether dexpantenol may interfere with fertility.
Driving and Using Machines
The influence of this medication on the ability to drive and use machines is negligible or insignificant.
Follow the administration instructions for this medication exactly as indicated by your doctor. If you have any doubts, consult your doctor or pharmacist again.
Adults over 18 years:
The recommended dose for postoperative intestinal atony is:
The recommended dose for Burning Feet Syndrome is:
If you use more Bepanmed than you should
No cases of disorders due to hypervitaminosis are known; Bepanmed is well tolerated even at high doses.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to a medical center or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Like all medications, this medication can cause side effects, although not everyone will experience them.
The following adverse reactions have been reported:
Reporting Side Effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store above 25°C.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medications at the pharmacy's SIGRE point. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Bepanmed Solution for Injection
Appearance of the Product and Contents of the Pack
Bepanmed is a solution for injection, a colorless to yellowish liquid, presented in 2 ml ampoules (of glass).
Each box contains 3 or 6 ampoules.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Bayer Hispania, S.L.
Av. Baix Llobregat, 3 – 5
08970 Sant Joan Despí (Barcelona)
Manufacturer:
DOPPEL FARMACEUTICI, S.R.L.
Via Volturno, 48 Quinto De Stampi
I-20089 Rozzano, Milan
Italy
Date of the Last Revision of this Package Leaflet:October 2017.
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BEPANMED 500 mg/2 ml INJECTABLE SOLUTION – subject to medical assessment and local rules.